Novo and Lilly just slashed prices on GLP-1 weight-loss drugs that recently cost over $1,000 a month. What happened?
In Baltimore, blue collar workers are fighting back, preparing for the "Green Workforce of the Future" and defending offshore ...
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...
With the BLACKFRIDAY50 code, BLACKSHEEP's already low prices become even more affordable: eco-responsible frames starting at $1.48 (regularly $2.95), complete single-vision prescription glasses as low ...
Biologic medicines—drugs with complex molecules developed in living cells—have saved lives and improved the quality of life ...
Biologics represented 5% of the drugs prescribed in the U.S. in 2024, but they accounted for more than half of the country’s ...
Lowering patients' drug costs requires reforms to the PBM market. These reforms should address PBMs' growing use of group ...
FDA aims to speed biosimilar approvals to increase competition, but experts warn drug prices may not drop quickly.
Just like the president who came before him, Trump is trying to sell the country on his plans to create factory jobs. The ...
President Donald Trump 's problems with fixing the high cost of living might be giving voters a feeling of déjà vu.
Trump administration drug deals link U.S. prices to global lows, aiming to cut costs via Pfizer, AstraZeneca, and TrumpRx in 2026.
Exxon Mobil (XOM) and Chevron (CVX), the two biggest U.S. oil giants, increased their production during Q3 despite forecasts for a global supply glut and weakening oil prices. The output hikes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results